captopril has been researched along with Attention Deficit Disorder with Hyperactivity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grabowska, EM; Pillidge, K; Porter, AJ; Stanford, SC | 1 |
| Ghanizadeh, A | 1 |
2 other study(ies) available for captopril and Attention Deficit Disorder with Hyperactivity
| Article | Year |
|---|---|
The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene 'knockout' mice: sex differences and implications for the treatment of attention deficit hyperactivity disorder.
Topics: Analysis of Variance; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Attention Deficit Disorder with Hyperactivity; Captopril; Choice Behavior; Disease Models, Animal; Female; Hyperkinesis; Imidazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Pyridines; Reaction Time; Receptors, Neurokinin-1; Sex Differentiation | 2015 |
Captopril as a novel possible treatment for children with ADHD and elevated lead level, a hypothesis.
Topics: Attention Deficit Disorder with Hyperactivity; Captopril; Child; Humans; Lead | 2011 |